Asixone 500 mg/vial (IM Injection)
500 mg vial: ৳ 130.00
Medicine Details
Category | Details |
---|---|
Generic | Ceftriaxone sodium |
Company | Asiatic laboratories ltd |
Also available as |
Indications
- Lower respiratory tract infections
- Acute Bacterial Otitis Media
- Skin and skin structure infections
- Urinary tract infections
- Gonorrhea
- Bacterial Septicemia
- Bone and joint infections
- Meningitis
- Prevention of postoperative infections
- Perioperative prophylaxis of infections associated with surgery
Pharmacology
- Broad-spectrum parenteral cephalosporin antibiotic
- Bactericidal activity against a wide range of Gram-positive and Gram-negative organisms
- Interferes with synthesis of bacterial cell wall
- Long plasma elimination half-life of 6 to 9 hours
- Not metabolized in the body
- Highly protein bound at 95%
- Stable in the presence of beta lactamases
Dosage
- Usual adult dose of 1 to 2 gm by intravenous or intramuscular administration
- Maximum dose of 4 gm/day for certain infections
- Surgical prophylaxis dose of 1 g IV as a single dose 30 to 120 minutes before surgery
- Usual infant and children dose of 50 to 75 mg/kg intravenous or intramuscular administration
- Duration of therapy: 4 to 14 days
Administration
- Preparation of Solutions for Intramuscular / Intravenous Injections
- Intramuscular administration over 2-4 minutes
- Intravenous administration over 30 minutes at concentration between 10 mg/mL and 40 mg/mL
- Patient tolerance test recommended before starting treatment
- Potency maintained for at least 6 hours at room temperature or 24 hours at 5°C
Interaction
- No reported drug interactions
Contraindications
- Hypersensitivity to cephalosporin antibiotics
Side Effects
- Gastro-intestinal effects including diarrhea, nausea and vomiting
- Cutaneous reactions including rash, pruritus, urticaria, edema and erythema multiforme
- Hematologic reactions including eosinophilia, thrombocytopenia, leucopenia, anemia and neutropenia
- Hepatic reactions including elevations of SGOT or SGPT, bilirubinemia
- CNS reactions including nervousness, confusion, sleep disturbances, headache, hyperactivity, convulsion, hypertonia and dizziness
- Local phlebitis following intravenous administration
Pregnancy & Lactation
- Safety not established in human pregnancy
- Caution advised when administered to lactating mothers
Precautions & Warnings
- Risk of anaphylactic shock
- Potential gallbladder sludge
- Regular blood picture checks during prolonged treatment
Use in Special Populations
- Avoid in neonates if premature and newborn (up to 28 days of age)
Overdose Effects
- No specific antidote
- Treatment should be symptomatic
Therapeutic Class
- Third generation Cephalosporins
Storage Conditions
- Store in a cool, dry place (below 30° C)
- Keep away from light and moisture
- Keep out of the reach of children